Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Olympus Surgical Technologies Europe
Age
22–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults (≥ 22 years)
Self-report of daytime somnolence
Body mass index (BMI) ≤ 32
Mild to moderate obstructive sleep apnea (AHI 10 - 30; lowest O2 sat ≥ 80%)
Evidence of palate and tongue base collapse on supine fiberoptic examination
Non-compliant with or refusal of continuous positive airway pressure therapy (CPAP) (\< 4 hours per night by patient report)
No prior surgical treatment for OSAS other than nasal surgery
Willing and capable of providing informed consent
You may not be if
Another significant sleep disorder (e.g., insomnia, periodic limb movement)
Tonsillar hypertrophy
Chronic Obstructive Pulmonary Disease (COPD)
Interstitial Lung Disease (ILD)
Cystic Fibrosis
Acute Repiratory Distress Syndrome (ARDS)
Nasal or supraglottic obstruction on fiberoptic examination
American Society of Anesthesiologists (ASA) class III ,IV, V
Latex allergy
Lidocaine allergy
Pregnancy or plans to become pregnant Note: women of childbearing potential must demonstrate a negative pregnancy test upon enrollment; those patients qualified to progress to RFA must also demonstrate a negative pregnancy test within 7 days prior to the date of RFA procedure.
Major depression or non-stabilized psychiatric disorder
Central or mixed apnea ≥ 10% of respiratory events
Participation in another clinical study (enrolled in any concurrent study) whose investigational plan is judged to interfere or affect any of the measures of this study
